medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2017, Número 2

<< Anterior Siguiente >>

Acta Med 2017; 15 (2)


Diagnóstico y tratamiento de los tumores malignos de piel

Telich TJE, Monter PA, Baldín AV, Apellaniz CA

Idioma: Español
Referencias bibliográficas: 38
Paginas: 154-160
Archivo PDF: 349.97 Kb.


RESUMEN

El cáncer de piel se ha convertido en un problema de salud pública debido a su alta incidencia y al porcentaje considerable que ocupa dentro de las principales neoplasias malignas. Existen diversos factores de riesgo para desarrollar esta patología, y se observó que la exposición a los rayos UV se encuentra dentro de los más importantes. Para su estudio se divide en dos tipos: el melanoma y cáncer de piel no melanoma, que a su vez se clasifica en carcinoma basocelular y espinocelular. La mayoría de los casos son prevenibles y tienen buena respuesta al tratamiento cuando son diagnosticados oportunamente; por ello, debe considerarse tema de relevancia dentro de la práctica médica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012; 166 (5): 1069-1080.

  2. Mohan SV, Chang AL. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep. 2014; 3: 40-45.

  3. SINAIS/SINAVE/DGE/SALUD/Perfil epidemiológico de los tumores malignos en México. México: 2011; 45.

  4. Gandhi SA, Kampp J. Skin cancer epidemiology, detection and management. Med Clin North Am. 2015; 99 (6): 1323-1335.

  5. Reinstadler DR, Sinha UK. Uncommon cutaneous neoplasms of the head and neck. Facial Plast Surg Clin North Am. 2012; 20 (4): 483- 491.

  6. Xiang F, Lucas R, Hales S, Neale R. Incidence of non-melanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012 empirical relationships. JAMA Dermatol. 2014; 150 (10): 1063-1071.

  7. Ouyang YH. Skin cancer of the head and neck. Semin Plast Surg. 2010; 24 (2): 117-126.

  8. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010; 375 (9715): 673-685.

  9. Gordon R. Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs. 2013; 29 (3): 160-169.

  10. Wu PA. Epidemiology and clinical features of basal cell carcinoma. UpToDate. 2014.

  11. Firnhaber JM. Diagnosis and treatment of basal cell and squemous cell carcinoma. Am Fam Physician. 2012; 86 (2): 161-168.

  12. Ibrahim O, Gastman B, Zhang A. Advances in diagnosis and treatment of nonmelanoma skin cancer. Ann Plast Surg. 2014; 73 (5): 615-619.

  13. Ermertcan AT, Hellings PW, Cingi C. Nonmelanoma skin cancer of the head and neck: nonsurgical treatment. Facial Plast Surg Clin North Am. 2012; 20 (4): 445-454.

  14. Akcam TM, Gubisch W, Unlu H. Nonmelanoma skin cancer of the head and neck: surgical treatment. Facial Plast Surg Clin North Am. 2012; 20 (4): 455-471.

  15. NCCN Clinical Practice Guidelines in Oncology. Basal cell skin cancer, Version 2.2016. Disponible en: https://www.nccn.org/professionals/ physician_gls/f_guidelines.asp

  16. Metterle L, Nelson C, Patel N. Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review. J Am Acad Dermatol. 2016; 74 (3): 552-557.

  17. Bahner JD, Bordeaux JS. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, iquimod, diclofenac, or what? Facts and controversies. Clin Dermatol. 2013; 31 (6): 792-798.

  18. Rong Y, Zuo L, Shang L, Bazan JG. Radiotherapy treatment for nonmelanoma skin cancer. Expert Rev Anticancer Ther. 2015; 15 (7): 765-776.

  19. Song F, Qureshi AA, Giovannucci EL, Fuchs CS, Chen WY, Stampfer MJ et al. Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med. 2013; 10 (4): e1001433.

  20. Veierød MB, Couto E, Lund E, Adami HO, Weiderpass E. Host characteristics, sun exposure, indoor tanning and risk of squamous cell carcinoma of the skin. Int J Cancer. 2014; 135 (2): 413-422.

  21. Leonardi-Bee J, Ellison T, Bath-Hextall F. Smoking and the risk of nonmelanoma skin cancer: systematic review and meta-analysis. Arch Dermatol. 2012; 148 (8): 939-946.

  22. Prieto-Granada C, Rodriguez-Waitkus P. Cutaneous squamous cell carcinoma and related entities: Epidemiology, clinical and histological features, and basic science overview. Curr Probl Cancer. 2015; 39 (4): 206-215.

  23. Martorell-Calatayud A, Sanmartín-Jiménez O, Cruz-Mojarrieta J, Guillén-Barona C. Cutaneous squamous cell carcinoma: defining the high-risk variant. Actas Dermosifiliogr. 2013; 104 (5): 367-379.

  24. Kallini J, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol. 2015; 54 (2): 130-140.

  25. Divine J, Stefaniwksy L, Reddy R, Padilla P, Hagele T, Patel NS et al. A comprehensive guide to the surgical management of nonmelanoma skin cancer. Curr Probl Cancer. 2015; 39 (4): 216-225.

  26. Metterle L, Russell JS, Patel NS. An overview of the medical management of nonmelanoma skin cancer. Curr Probl Cancer. 2015; 39 (4): 226-226.

  27. NCCN Clinical Practice Guidelines in Oncology. Squamous cell skin cancer, Version 1.2016. Disponible en: https://www.nccn.org/ professionals/physician_gls/f_guidelines.asp

  28. Lansbury L, Bath-Hextall F, Perkins W, Stanton W, Leonardi-Bee J. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ. 2013; 347: f6153.

  29. Kyrgidis A, Tzellos TG, Kechagias N, Patrikidou A, Xirou P, Kitikidou K et al. Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival. Eur J Cancer. 2010; 46 (9): 1563-1572.

  30. Broughman ND, Tan ST. The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma —Implications on the T-classification system. J Surg Oncol. 2014; 110 (7): 876-882.

  31. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64 (1): 9-29.

  32. Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014; 383 (9919): 816-827.

  33. Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res (Phila). 2010; 3 (2): 233-245.

  34. Dickson PV, Gershenwald JE. Staging and prognosis of cutaneous melanoma. Surg Oncol Clin N Am. 2011; 20 (1): 1-17.

  35. Ott PA, Berman RS. Surgical approach to primary cutaneous melanoma. Surg Oncol Clin N Am. 2011; 20 (1): 39-56.

  36. NCCN Clinical Practice Guidelines in Oncology. Melanoma, Version 3.2016. Disponible en: https://www.nccn.org/professionals/ physician_gls/f_guidelines.asp

  37. Farma JM, Kulkarno N, Hsu C. Surgical management of primary and recurrent melanoma. Surg Oncol Clin N Am. 2015; 24 (2): 239-247.

  38. Johnson TM. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2013; 69 (6): 1049-1050.




2020     |     www.medigraphic.com